{"url_path":"/sec/tdoc/8-k/2026-05-21/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1477449/0001477449-26-000030-index.html","accession_number":"0001477449-26-000030","cik":"0001477449","ticker":"TDOC","issuer_name":"Teladoc Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477449/0001477449-26-000030-index.html","primary_entity_key":"0001477449","primary_entity_name":"Teladoc Health, Inc."},"word_count":307,"has_tables":true,"body_markdown":"tdoc-20260521\nFALSE0001477449155 E 44th StreetSuite 1700New YorkNY1001700014774492026-05-212026-05-210001477449dei:FormerAddressMember2026-05-212026-05-21\n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWashington, D.C. 20549\n\n___________________________________\n\nFORM 8-K\n\n___________________________________\n\nCURRENT REPORT\n\nPursuant to Section 13 or 15(d)\n\nof the Securities Exchange Act of 1934\n\nDate of Report (Date of earliest event reported) May 21, 2026\n\n___________________________________\n\nTeladoc Health, Inc.\n\n(Exact name of registrant as specified in its charter)\n\n___________________________________\n\nDelaware\n\n(State or other jurisdiction of\n\nincorporation)\n\n001-37477\n\n(Commission File Number)\n\n04-3705970\n\n(I.R.S. Employer Identification No.)\n\n155 E 44th Street, Suite 1700\n\nNew York, NY 10017\n\n(Address of principal executive offices and zip code)\n\n(203) 635-2002\n\n(Registrant's telephone number, including area code)\n\n___________________________________\n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n☐\n\nWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n☐\n\nSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n☐\n\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n☐\n\nPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\nSecurities registered pursuant to Section 12(b) of the Act:\n\nTitle of each class\n\nTrading Symbol\n\nName of each exchange on which registered\n\nCommon stock, par value $0.001 per share\n\nTDOC\n\nThe New York Stock Exchange\n\nIndicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\nEmerging growth company    ☐\n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐"}